ATE450270T1 - Impstoff gegen mikrobielle pathogenen - Google Patents

Impstoff gegen mikrobielle pathogenen

Info

Publication number
ATE450270T1
ATE450270T1 AT01963230T AT01963230T ATE450270T1 AT E450270 T1 ATE450270 T1 AT E450270T1 AT 01963230 T AT01963230 T AT 01963230T AT 01963230 T AT01963230 T AT 01963230T AT E450270 T1 ATE450270 T1 AT E450270T1
Authority
AT
Austria
Prior art keywords
heat shock
vaccine
present
shock protein
repressor
Prior art date
Application number
AT01963230T
Other languages
English (en)
Inventor
Camilo Colaco
Original Assignee
Immunobiology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunobiology Ltd filed Critical Immunobiology Ltd
Application granted granted Critical
Publication of ATE450270T1 publication Critical patent/ATE450270T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6043—Heat shock proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT01963230T 2000-09-04 2001-09-04 Impstoff gegen mikrobielle pathogenen ATE450270T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0021757.0A GB0021757D0 (en) 2000-09-04 2000-09-04 Vaccine against microbial pathogens
PCT/GB2001/003964 WO2002020045A2 (en) 2000-09-04 2001-09-04 Vaccine against microbial pathogens

Publications (1)

Publication Number Publication Date
ATE450270T1 true ATE450270T1 (de) 2009-12-15

Family

ID=9898866

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01963230T ATE450270T1 (de) 2000-09-04 2001-09-04 Impstoff gegen mikrobielle pathogenen

Country Status (15)

Country Link
US (1) US20050232946A1 (de)
EP (1) EP1315518B1 (de)
JP (1) JP2004508339A (de)
CN (1) CN1452495A (de)
AT (1) ATE450270T1 (de)
AU (1) AU2001284261A1 (de)
CA (1) CA2421229A1 (de)
DE (1) DE60140681D1 (de)
DK (1) DK1315518T3 (de)
ES (1) ES2337653T3 (de)
GB (1) GB0021757D0 (de)
IL (1) IL154727A0 (de)
PT (1) PT1315518E (de)
WO (1) WO2002020045A2 (de)
ZA (1) ZA200301759B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007003111A (es) * 2004-09-21 2007-05-24 Astellas Pharma Inc Derivados de aminoalcohol.
KR20090064412A (ko) 2006-09-01 2009-06-18 씨에스엘 리미티드 면역 반응을 유발 또는 유도하는 방법
WO2009021291A1 (en) * 2007-08-16 2009-02-19 The University Of Sydney Mycobacterium vaccine formulation
US8999353B2 (en) 2007-10-12 2015-04-07 Csl Limited Method of eliciting an immune response against pandemic influenza virus
GB0910591D0 (en) 2009-06-19 2009-07-29 Immunobiology Ltd Method for the purification of protein complexes
GB0916557D0 (en) 2009-09-21 2009-10-28 Health Prot Agency Commensal neisserial stress protein complexes
GB201104897D0 (en) 2011-03-23 2011-05-04 Immunobiology Ltd Method for the production of protein complexes and vaccine compositions comprising the same
EA201391553A1 (ru) * 2011-04-20 2014-03-31 Майко Байо, Инк. Композиция и способ усиления иммунного ответа

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3785404T2 (de) * 1986-08-18 1993-07-29 British Tech Group Impfstoffe.
US5776724A (en) * 1988-10-24 1998-07-07 Yale University Chaperonin-mediated protein folding
JPH03204820A (ja) * 1989-10-12 1991-09-06 Nippon Saibai Suisan Kk エビ類の細菌性疾病予防ワクチン及びその製造法
US5843460A (en) * 1993-05-19 1998-12-01 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
WO1995014093A1 (en) * 1993-05-19 1995-05-26 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides
JPH0748398A (ja) * 1993-08-03 1995-02-21 Nippon Oil Co Ltd 変性蛋白質の再生方法及び変性蛋白質再生剤
US6420127B1 (en) * 1994-11-18 2002-07-16 Washington University Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections
US6872542B1 (en) * 1993-11-18 2005-03-29 Siga Pharmaceuticals, Inc. Treatment or prophylaxis of diseases caused by pilus-forming bacteria
US5961979A (en) * 1994-03-16 1999-10-05 Mount Sinai School Of Medicine Of The City University Of New York Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
AP9701163A0 (en) * 1995-06-07 1998-01-31 Biochem Vaccines Inc Streptococcal heat shock proteins members of the HSP70 family.
US5935576A (en) * 1995-09-13 1999-08-10 Fordham University Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
BR9611623A (pt) * 1995-11-30 1999-12-28 Daratech Pty Ltd Composição de vacina e processo para a profilaxia ou tratamento de infecção em um animal ou pássaro por lawsonia intracelularis ou microorganismo relacionado, molécula de ácido nucleico isolada, e, vacina genética.
US5747332A (en) * 1996-09-20 1998-05-05 University Of New Mexico Methods for purifying and synthesizing heat shock protein complexes
EP0950061A4 (de) * 1996-09-20 2000-04-12 Univ New Mexico Hitzeschockproteinkomplexe
US6331388B1 (en) * 1997-10-17 2001-12-18 Wisconsin Alumni Research Foundation Immune response enhancer
US5948646A (en) * 1997-12-11 1999-09-07 Fordham University Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
US6500434B1 (en) * 1998-04-23 2002-12-31 Medimmune, Inc. Chaperone and adhesin proteins; vaccines, diagnostics and method for treating infections
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
EP1105159A2 (de) * 1998-06-19 2001-06-13 Mérieux Oravax Lt und ct in verfahren zur parenteralen immunisierung gegen helicobacter-infektionen
GB9818133D0 (en) * 1998-08-19 1998-10-14 Quadrant Holdings Cambridge Vaccine
CA2363146A1 (en) * 1999-02-22 2000-08-31 Solomon Langermann Caulobacter lps immunoadjuvant
US7041465B1 (en) * 1999-08-11 2006-05-09 Washington University Anti-bacterial compounds directed against pilus biogenesis, adhesion and activity; co-crystals of pilus subunits and methods of use thereof
GB9919734D0 (en) * 1999-08-19 1999-10-20 Colaco Camilo Vaccines from infectious agents
US6677139B1 (en) * 1999-12-23 2004-01-13 Genecor International, Inc. Methods for production of proteins in host cells
GB0004547D0 (en) * 2000-02-23 2000-04-19 Immunobiology Ltd Screening method for novel vaccine candidates and compositions obtained thereby
EP1284986A4 (de) * 2000-04-17 2005-08-24 James E Rothman Komplexierung von protein-antigenen und hitzeschockproteinen mittels javelin
CN1107681C (zh) * 2000-08-11 2003-05-07 中国科学院微生物研究所 乙肝病毒抗原多肽与热休克蛋白的复合物及其应用
US6932985B2 (en) * 2000-10-10 2005-08-23 Auburn University Azide method and composition for controlling deleterious organisms
WO2002059156A2 (en) * 2000-12-22 2002-08-01 Medimmune, Inc. Therapeutic compounds structurally-linked to bacterial polypeptides
AU2003216288B2 (en) * 2002-02-13 2009-09-24 Duke University Modulation of immune response by non-peptide binding stress response polypeptides
WO2003074003A2 (en) * 2002-03-01 2003-09-12 Applied Immune Technologies Immunogens for treatment of neoplastic and infectious disease
WO2004035602A2 (en) * 2002-05-02 2004-04-29 University Of Connecticut Health Center Using heat shock proteins and alpha-2-macroglobulins to increase immune response to vaccines

Also Published As

Publication number Publication date
PT1315518E (pt) 2010-03-05
ES2337653T3 (es) 2010-04-28
WO2002020045A2 (en) 2002-03-14
DK1315518T3 (da) 2010-04-19
JP2004508339A (ja) 2004-03-18
GB0021757D0 (en) 2000-10-18
EP1315518B1 (de) 2009-12-02
DE60140681D1 (de) 2010-01-14
WO2002020045A3 (en) 2002-10-31
AU2001284261A1 (en) 2002-03-22
US20050232946A1 (en) 2005-10-20
CN1452495A (zh) 2003-10-29
ZA200301759B (en) 2004-06-22
CA2421229A1 (en) 2002-03-14
EP1315518A2 (de) 2003-06-04
IL154727A0 (en) 2003-10-31

Similar Documents

Publication Publication Date Title
ATE219948T1 (de) Rekombinante impfstoffe die immunogene attenuierte rpos-positiv phentotyp bakterien enthalten
NO20075727L (no) Vaksineblanding omfattende B-subenhet av et E.coli varmetoksin og et antigen og en adjuvans
ATE450270T1 (de) Impstoff gegen mikrobielle pathogenen
DE602004028029D1 (en) Rwendung
ATE173166T1 (de) Neue bakterielle impfstoffe unter verwendung von impfstämmen von pathogenen bakterien
ATE315090T1 (de) Impfstoffherstellung des bacillus anthracis schutzantigens
ATE507286T1 (de) Immunisierung von fischen gegen virusinfektion
WO2001063278A3 (en) Antigenic fragments associated with stress-induced proteins and their use as vaccines
DE60218327D1 (de) Inaktivierte immunogene bakterielle ganzzell-zusammensetzungen
BR0110278A (pt) Composição de vacina, anticorpo ou anti-soro, métodos de produção de um anticorpo ou de um anti-soro e de imunização de um animal contra um ectoparasita que se alimenta de sangue, proteìna de cemento de carrapato, e, uso de uma proteìna de cemento de carrapato
CY1105947T1 (el) Νουκλεϊνικα οξεα και πρωτεϊνες του γονιδιου mhp3 του mycoplasma hyopneumoniae και χρησεις αυτων
ATE542544T1 (de) Pro-apoptotische bakterielle impfstoffe zur verbesserung der zellulären immunantwort
ATE494377T1 (de) Vakzine gegen ipnv die aus hefezellen isoliert werden
ATE449610T1 (de) Stress-proteine extrazellulärer pathogene als impfstoffe gegen infektiöse erreger
BRPI0309787E2 (pt) Polipeptídeo isolado, composição de vacina anti-carrapato de espécies múltiplas, molécula de cdna isolada, vetor de expressão, célula isolada, vacina anti-carrapato de espécie múltipla, e, método de induzir uma resposta imune em um mamífero contra a infestação de carrapato de espécie múltipla e seus patógenos associados
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
PT1370668E (pt) Vacinas de vector baseadas em leporipox
BRPI0604365A (pt) polipeptìdeo isolado, composição de vacina anti-carrapato de múltiplas espécies, e, uso dos mesmos
DK1387693T3 (da) Saponininaktiveret mykoplasmavaccine
GB9404577D0 (en) Vaccine compositions
WO2006037383A8 (en) Piscirickettsia salmonis antigens and use thereof
WO2002067982A3 (en) Mycobacterial vaccines
AP2003002944A0 (en) Method to generate non virulent microorganisms from pathogenic ones through permanent genetic modification of their biological membrane for vaccine production.
CU23358B7 (es) Vacuna que comprende una proteína cemento de garrapata

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1315518

Country of ref document: EP